Secondary Logo

Most Popular Articles

Multicenter Comparison of Contrast-Enhanced FDG PET/CT and 64-Slice Multi–Detector-Row CT for Initial Staging and Response Evaluation at the End of Treatment in Patients With Lymphoma

Gómez León, Nieves; Delgado-Bolton, Roberto C.; del Campo del Val, Lourdes; More

Clinical Nuclear Medicine. 42(8):595-602, August 2017.

SPECT/CT With the PSMA Ligand 99mTc-MIP-1404 for Whole-Body Primary Staging of Patients With Prostate Cancer

Schmidkonz, Christian; Cordes, Michael; Beck, Michael; More

Clinical Nuclear Medicine. 43(4):225-231, April 2018.

Prostate-Specific Antigen and Prostate-Specific Antigen Velocity as Threshold Indicators in 11C-Acetate PET/CTAC Scanning for Prostate Cancer Recurrence

Dusing, Reginald W.; Peng, Warner; Lai, Sue-Min; More

Clinical Nuclear Medicine. 39(9):777-783, September 2014.

Quantitation of Perfused Lung Volume Using Hybrid SPECT/CT Allows Refining the Assessment of Lung Perfusion and Estimating Disease Extent in Chronic Thromboembolic Pulmonary Hypertension

Derlin, Thorsten; Kelting, Catharina; Hueper, Katja; More

Clinical Nuclear Medicine. 43(6):e170-e177, June 2018.

Characterization of Diffuse Gliomas With Histone H3-G34 Mutation by MRI and Dynamic 18F-FET PET

Vettermann, Franziska J.; Felsberg, Jörg; Reifenberger, Guido; More

Clinical Nuclear Medicine. 43(12):895-898, December 2018.

223Ra Therapy in Patients With Advanced Castration-Resistant Prostate Cancer With Bone Metastases: Lessons from Daily Practice

van der Doelen, Maarten J.; Kuppen, Malou C.P.; Jonker, Marianne A.; More

Clinical Nuclear Medicine. 43(1):9-16, January 2018.

Pediatric 131I-MIBG Therapy for Neuroblastoma: Whole-Body 131I-MIBG Clearance, Radiation Doses to Patients, Family Caregivers, Medical Staff, and Radiation Safety Measures

Willegaignon, José; Crema, Karin Paola; Oliveira, Nathaliê Canhameiro; More

Clinical Nuclear Medicine. 43(8):572-578, August 2018.

ACR–ACNM Practice Parameter for the Performance of Fluorine-18 Fluciclovine-PET/CT for Recurrent Prostate Cancer

Savir-Baruch, Bital; Banks, Kevin P.; McConathy, Jonathan E.; More

Clinical Nuclear Medicine. 43(12):909-917, December 2018.

89Zr-Trastuzumab PET/CT for Detection of Human Epidermal Growth Factor Receptor 2–Positive Metastases in Patients With Human Epidermal Growth Factor Receptor 2–Negative Primary Breast Cancer

Ulaner, Gary A.; Hyman, David M.; Lyashchenko, Serge K.; More

Clinical Nuclear Medicine. 42(12):912-917, December 2017.